Search results for "Heart Failure"
Age only one consideration in post-MI drug therapy
To determine the best therapy for elderly patients after a heart attack, physicians should get to know their goals for their lives.
https://immattersacp.org/archives/2020/09/age-only-one-consideration-in-post-mi-drug-therapy.htm
1 Sep 2020
Managing HIV with testing, prevention
Antiretroviral therapy has made an impact in treating HIV, but preexposure prophylaxis has created a huge opportunity in preventing infection, with internists poised to play a role.
https://immattersacp.org/archives/2020/03/managing-hiv-with-testing-prevention.htm
1 Mar 2020
ARBs may offer same efficacy, better tolerability than ACE inhibitors
Meta-regression analysis showed that the difference between angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) compared with placebo was due to a higher placebo event rate in the ACE inhibitor trials for the outcome of all-cause mortality, cardiovascular death, and myocardial infarction.
https://immattersacp.org/weekly/archives/2016/01/12/6.htm
12 Jan 2016
Correcting medicine's use of race in clinical algorithms
Recent efforts have pushed institutions to reconsider the use of race not just in estimating kidney function, but in a variety of algorithms and scores.
https://immattersacp.org/archives/2021/05/correcting-medicines-use-of-race-in-clinical-algorithms.htm
1 May 2021
Guidance issued on drug-drug interactions for statins, heart meds
A new statement from the American Heart Association recommends that in patients taking amlodipine combined with simvastatin or lovastatin, the dosage of either statin should not exceed 20 mg/d, and for patients in whom statin-fibrate therapy is indicated, fenofibrate or fenofibric acid is preferred because of a lower rate of drug-drug interactions.
https://immattersacp.org/weekly/archives/2016/10/25/2.htm
25 Oct 2016
Palliative care for a pandemic
Diane E. Meier, MD, FACP, director of the Center to Advance Palliative Care, discusses how palliative care can be applied to the COVID-19 pandemic.
https://immattersacp.org/archives/2020/05/palliative-care-for-a-pandemic.htm
1 May 2020
MKSAP Quiz: evaluation of moderate aortic regurgitation
A 47-year-old man is evaluated during a routine examination. He has no symptoms. Medical history is significant for a bicuspid aortic valve. He is not taking any medications. Following a physical exam, cardiac exam, and echocardiogram, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2016/10/18/3.htm
18 Oct 2016
AHA evaluates heart failure risks from prescription drugs, OTCs, alternative products
The scientific statement identifies prescription medications that may exacerbate underlying myocardial dysfunction, prescription drugs known to cause direct myocardial toxicity, and the sodium level of some over-the-counter medications, among other concerns.
https://immattersacp.org/weekly/archives/2016/07/19/5.htm
19 Jul 2016
Internal medicine looks ahead
This issue addresses ACP's virtual meeting for student members, advances in heart failure comanagement, and conference coverage.
https://immattersacp.org/archives/2021/07/internal-medicine-looks-ahead.htm
1 Jul 2021
MKSAP Quiz: Gradually progressive abdominal distention
A 68-year-old woman is evaluated for a 3-month history of gradually progressive abdominal distention. Her medical history is notable for a 20-year history of obesity, type 2 diabetes mellitus, hyperlipidemia, and hypertension. She also has had a 10-year history of elevation of serum aminotransferase levels, which was attributed to nonalcoholic fatty liver disease. She does not consume alcohol. Her medications are metformin, lisinopril, low-dose aspirin, and simvastatin. Following a physical exam and lab studies, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2016/11/08/3.htm
8 Nov 2016